Clinical Trial Update: A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial evaluating Crolibulin (EPC2407) in combination with cisplatin in adults with solid tumors, focusing on anaplastic thyroid carcinoma;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Crolibulin (EPC2407)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Solid Tumor, Anaplastic Thyroid Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-12-31